Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1986 Dec;62(734):1081–1087. doi: 10.1136/pgmj.62.734.1081

Anticardiolipin antibodies--clinical associations.

R A Asherson 1, E N Harris 1
PMCID: PMC2418945  PMID: 3309910

Full text

PDF
1081

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson N. E., Ali M. R. The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension. Ann Rheum Dis. 1984 Oct;43(5):760–763. doi: 10.1136/ard.43.5.760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Angles-Cano E., Sultan Y., Clauvel J. P. Predisposing factors to thrombosis in systemic lupus erythematosus: possible relation to endothelial cell damage. J Lab Clin Med. 1979 Aug;94(2):312–323. [PubMed] [Google Scholar]
  3. Asherson R. A., Derksen R. H., Harris E. N., Bingley P. J., Hoffbrand B. I., Gharavi A. E., Kater L., Hughes G. R. Large vessel occlusion and gangrene in systemic lupus erythematosus and "lupus-like" disease. A report of six cases. J Rheumatol. 1986 Aug;13(4):740–747. [PubMed] [Google Scholar]
  4. Asherson R. A., Harris E. N., Bernstein R. M., Mackworth-Young C. G., Hughes G. R. Immunological studies in 'primary' idiopathic pulmonary hypertension. Eur J Rheumatol Inflamm. 1984;7(3):75–79. [PubMed] [Google Scholar]
  5. Asherson R. A., Harris E. N., Gharavi A. E., Englert H. E., Hughes G. R. Aortic arch syndrome associated with anticardiolipin antibodies and the lupus anticoagulant: comment on Ferrante paper. Arthritis Rheum. 1985 May;28(5):594–595. doi: 10.1002/art.1780280525. [DOI] [PubMed] [Google Scholar]
  6. Asherson R. A., Lanham J. G., Hull R. G., Boey M. L., Gharavi A. E., Hughes G. R. Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant". Clin Exp Rheumatol. 1984 Jan-Mar;2(1):75–79. [PubMed] [Google Scholar]
  7. Asherson R. A., Mackworth-Young C. G., Boey M. L., Hull R. G., Saunders A., Gharavi A. E., Hughes G. R. Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) 1983 Oct 8;287(6398):1024–1025. doi: 10.1136/bmj.287.6398.1024-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Asherson R. A., Morgan S. H., Harris E. N., Gharavi A. E., Krausz T., Hughes G. R. Arterial occlusion causing large bowel infarction--a reflection of clotting diathesis in SLE. Clin Rheumatol. 1986 Jan;5(1):102–106. doi: 10.1007/BF02030977. [DOI] [PubMed] [Google Scholar]
  9. Asherson R. A., Morgan S. H., Harris N., Gharavi A. E., Hughes G. R., Millar A. B. Pulmonary hypertension and chronic cutaneous lupus erythematosus: association with the lupus anticoagulant. Arthritis Rheum. 1985 Jan;28(1):118–118. doi: 10.1002/art.1780280121. [DOI] [PubMed] [Google Scholar]
  10. Asherson R. A., Oakley C. M. Pulmonary hypertension and systemic lupus erythematosus. J Rheumatol. 1986 Feb;13(1):1–5. [PubMed] [Google Scholar]
  11. Boey M. L., Colaco C. B., Gharavi A. E., Elkon K. B., Loizou S., Hughes G. R. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) 1983 Oct 8;287(6398):1021–1023. doi: 10.1136/bmj.287.6398.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Branch D. W., Scott J. R., Kochenour N. K., Hershgold E. Obstetric complications associated with the lupus anticoagulant. N Engl J Med. 1985 Nov 21;313(21):1322–1326. doi: 10.1056/NEJM198511213132104. [DOI] [PubMed] [Google Scholar]
  13. Copeman P. W. Livedo reticularis. Signs in the skin of disturbance of blood viscosity and of blood flow. Br J Dermatol. 1975 Nov;93(5):519–529. doi: 10.1111/j.1365-2133.1975.tb02244.x. [DOI] [PubMed] [Google Scholar]
  14. De Wolf F., Carreras L. O., Moerman P., Vermylen J., Van Assche A., Renaer M. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol. 1982 Apr 1;142(7):829–834. doi: 10.1016/s0002-9378(16)32527-3. [DOI] [PubMed] [Google Scholar]
  15. Elias M., Eldor A. Thromboembolism in patients with the 'lupus'-type circulating anticoagulant. Arch Intern Med. 1984 Mar;144(3):510–515. [PubMed] [Google Scholar]
  16. GOLDEN R. L. Livedo reticularis in systemic lupus erythematosus. Arch Dermatol. 1963 Mar;87:299–301. doi: 10.1001/archderm.1963.01590150015002. [DOI] [PubMed] [Google Scholar]
  17. Gardner-Medwin D. Recognising and preventing Duchenne muscular dystrophy. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1083–1084. doi: 10.1136/bmj.287.6399.1083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hainaut P., Lavenne E., Magy J. M., Lebacq E. G. Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease. Clin Rheumatol. 1986 Jan;5(1):96–101. doi: 10.1007/BF02030976. [DOI] [PubMed] [Google Scholar]
  19. Hall S., Buettner H., Luthra H. S. Occlusive retinal vascular disease in systemic lupus erythematosus. J Rheumatol. 1984 Dec;11(6):846–850. [PubMed] [Google Scholar]
  20. Hamsten A., Norberg R., Björkholm M., de Faire U., Holm G. Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events. Lancet. 1986 Jan 18;1(8473):113–116. doi: 10.1016/s0140-6736(86)92258-0. [DOI] [PubMed] [Google Scholar]
  21. Harris E. N., Asherson R. A., Gharavi A. E., Morgan S. H., Derue G., Hughes G. R. Thrombocytopenia in SLE and related autoimmune disorders: association with anticardiolipin antibody. Br J Haematol. 1985 Feb;59(2):227–230. doi: 10.1111/j.1365-2141.1985.tb02988.x. [DOI] [PubMed] [Google Scholar]
  22. Harris E. N., Gharavi A. E., Hegde U., Derue G., Morgan S. H., Englert H., Chan J. K., Asherson R. A., Hughes G. R. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. Br J Haematol. 1985 Feb;59(2):231–234. doi: 10.1111/j.1365-2141.1985.tb02989.x. [DOI] [PubMed] [Google Scholar]
  23. Harris E. N., Hughes G. R. Cerebral disease in systemic lupus erythematosus. Springer Semin Immunopathol. 1985;8(3):251–266. doi: 10.1007/BF00197299. [DOI] [PubMed] [Google Scholar]
  24. Hughes G. R., Mackworth-Young C., Harris E. N., Gharavi A. E. Veno-occlusive disease in systemic lupus erythematosus: possible association with anticardiolipin antibodies? Arthritis Rheum. 1984 Sep;27(9):1071–1071. doi: 10.1002/art.1780270922. [DOI] [PubMed] [Google Scholar]
  25. Hughes G. R. The Prosser-White oration 1983. Connective tissue disease and the skin. Clin Exp Dermatol. 1984 Nov;9(6):535–544. doi: 10.1111/j.1365-2230.1984.tb00856.x. [DOI] [PubMed] [Google Scholar]
  26. Hughes G. R. The anticardiolipin syndrome. Clin Exp Rheumatol. 1985 Oct-Dec;3(4):285–286. [PubMed] [Google Scholar]
  27. Jaffe W. M., Wattie W. J., Rutland M. D., Lubbe W. F. Extensive pulmonary embolism associated with lupus anticoagulant. N Z Med J. 1985 Mar 27;98(775):184–185. [PubMed] [Google Scholar]
  28. Johansson E. A., Niemi K. M., Mustakallio K. K. A peripheral vascular syndrome overlapping with systemic lupus erythematosus. Recurrent venous thrombosis and hemorrhagic capillary proliferation with circulating anticoagulants and false-positive seroreactions for syphilis. Dermatologica. 1977;155(5):257–267. [PubMed] [Google Scholar]
  29. Jonas J., Kölble K., Völcker H. E., Kalden J. R. Central retinal artery occlusion in Sneddon's disease associated with antiphospholipid antibodies. Am J Ophthalmol. 1986 Jul 15;102(1):37–40. doi: 10.1016/0002-9394(86)90206-0. [DOI] [PubMed] [Google Scholar]
  30. Jouquan J., Pennec Y., Mottier D., Youinou P., Cledes J., Leroy J. P., Le Menn G. Accelerated hypertension associated with lupus anticoagulant and false-positive VDRL in systemic lupus erythematosus. Arthritis Rheum. 1986 Jan;29(1):147–147. doi: 10.1002/art.1780290121. [DOI] [PubMed] [Google Scholar]
  31. Kant K. S., Pollak V. E., Weiss M. A., Glueck H. I., Miller A. N., Hess E. V. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore) 1981 Mar;60(2):71–86. doi: 10.1097/00005792-198103000-00001. [DOI] [PubMed] [Google Scholar]
  32. Lockshin M. D., Druzin M. L., Goei S., Qamar T., Magid M. S., Jovanovic L., Ferenc M. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med. 1985 Jul 18;313(3):152–156. doi: 10.1056/NEJM198507183130304. [DOI] [PubMed] [Google Scholar]
  33. Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet. 1983 Jun 18;1(8338):1361–1363. doi: 10.1016/s0140-6736(83)92141-4. [DOI] [PubMed] [Google Scholar]
  34. Lubbe W. F., Butler W. S., Palmer S. J., Liggins G. C. Fetal survival after prednisone suppression of maternal lupus-anticoagulant. Lancet. 1983 Jun 18;1(8338):1361–1363. doi: 10.1016/s0140-6736(83)92141-4. [DOI] [PubMed] [Google Scholar]
  35. Mueh J. R., Herbst K. D., Rapaport S. I. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med. 1980 Feb;92(2 Pt 1):156–159. doi: 10.7326/0003-4819-92-2-156. [DOI] [PubMed] [Google Scholar]
  36. Nilsson I. M., Astedt B., Hedner U., Berezin D. Intrauterine death and circulating anticoagulant ("antithromboplastin"). Acta Med Scand. 1975 Mar;197(3):153–159. doi: 10.1111/j.0954-6820.1975.tb04897.x. [DOI] [PubMed] [Google Scholar]
  37. Oppenheimer S., Hoffbrand B. I. Optic neuritis and myelopathy in systemic lupus erythematosus. Can J Neurol Sci. 1986 May;13(2):129–132. doi: 10.1017/s0317167100036064. [DOI] [PubMed] [Google Scholar]
  38. Peck B., Hoffman G. S., Franck W. A. Thrombophlebitis in systemic lupus erythematosus. JAMA. 1978 Oct 13;240(16):1728–1730. [PubMed] [Google Scholar]
  39. Quimby S. R., Perry H. O. Livedo reticularis and cerebrovascular accidents. J Am Acad Dermatol. 1980 Oct;3(4):377–383. doi: 10.1016/s0190-9622(80)80331-8. [DOI] [PubMed] [Google Scholar]
  40. Roudot-Thoraval F., Gouault-Heilmann M., Zafrani E. S., Barge J., Dhumeaux D. Budd-Chiari syndrome and the lupus anticoagulant. Gastroenterology. 1985 Feb;88(2):605–605. doi: 10.1016/0016-5085(85)90557-8. [DOI] [PubMed] [Google Scholar]
  41. SNEDDON I. B. CEREBRO-VASCULAR LESIONS AND LIVEDO RETICULARIS. Br J Dermatol. 1965 Apr;77:180–185. doi: 10.1111/j.1365-2133.1965.tb14628.x. [DOI] [PubMed] [Google Scholar]
  42. Sanfelippo M. J., Drayna C. J. Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis. Am J Clin Pathol. 1982 Mar;77(3):275–279. doi: 10.1093/ajcp/77.3.275. [DOI] [PubMed] [Google Scholar]
  43. Shapiro S. S., Thiagarajan P. Lupus anticoagulants. Prog Hemost Thromb. 1982;6:263–285. [PubMed] [Google Scholar]
  44. Stuart M. J., Clark D. A., Sunderji S. G., Allen J. B., Yambo T., Elrad H., Slott J. H. Decrease prostacyclin production: a characteristic of chronic placental insufficiency syndromes. Lancet. 1981 May 23;1(8230):1126–1128. doi: 10.1016/s0140-6736(81)92298-4. [DOI] [PubMed] [Google Scholar]
  45. Thomas D. J., Kirby J. D., Britton K. E., Galton D. J. Livedo reticularis and neurological lesions. Br J Dermatol. 1982 Jun;106(6):711–712. doi: 10.1111/j.1365-2133.1982.tb11688.x. [DOI] [PubMed] [Google Scholar]
  46. Thomas D., Byrne P. D., Travers R. L. Systemic lupus erythematosus presenting as post-partum chorea. Aust N Z J Med. 1979 Oct;9(5):568–570. doi: 10.1111/j.1445-5994.1979.tb03397.x. [DOI] [PubMed] [Google Scholar]
  47. Vaziri N. D., Toohey J., Powers D., Keegan K., Gupta A., Alikhani S., Mashood M., Barbari A. Activation of intrinsic coagulation pathway in pre-eclampsia. Am J Med. 1986 Jan;80(1):103–107. doi: 10.1016/0002-9343(86)90056-2. [DOI] [PubMed] [Google Scholar]
  48. Walsh S. W. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol. 1985 Jun 1;152(3):335–340. doi: 10.1016/s0002-9378(85)80223-4. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES